Intrivo is a digital health company whose mission is to help people live happier, healthier and longer lives by providing them with intuitive tools and comprehensive health information to steward them across their entire health journey. In the midst of the current COVID-19 pandemic, we’ve been focused on helping companies reopen the economy, and individuals rediscover and reconnect through the use of rapid tests. We are the exclusive U.S. commercialization partner to Access Bio, an innovative diagnostics company that has received EUA approval for their CareStart™ COVID-19 Antigen test (as well as the CareStart PCR and Antibody tests). This CareStart™ antigen test gives results in 10 minutes with no additional equipment needed.
Company Details
- Employees
- 21
- Founded
- -
- Address
- Miami, Florida, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.intrivo.com
- Keywords
- Marina Del Rey.
- HQ
- Miami, Florida
Intrivo Questions
Intrivo's website is http://www.intrivo.com
Intrivo's LinkedIn profile is https://www.linkedin.com/company/weareintrivo
Intrivo has
21 employees.
View email and phone details for 21
employees at Intrivo.
Intrivo's industry is
Biotechnology Research
Intrivo's top competitors are
Openloop,
Rise Medical,
Wells Bio,
Scene,
Terasaki Institute For Biomedical Innovation (Tibi),
Myocene,
Audiencex,
Chyron,
Access Bio, Inc,
Bella La Vita Company.
Intrivo's categories are Biotechnology Research
Intrivo's founding year is 2020
